Our Approach

Finding the right drug for you
Rare & Neglected Diseases

Channelopathies,
Neuropathies &
Muscle Disorders

Drug Repurposing

FDA-approved Drugs,
Natural Products &
Shelved Assets

Drug Discovery

High-Throughput,
Lead Identification &
Combination Testing

Dose Improvement Trials

Dose-Responses,
Scheduling Optimization &
Delivery Testing

Our Technology

High-throughput, personalized drug profiling
The Personalized Medicine Approach



Using patient-derived (ex vivo) tissues, our novel electrophysiological technology - HiDAC™ - allows for functional assessment of disease-relevant mutant proteins, in order to evaluate drug efficacy/dosing as well as determine the best-in-class therapy for each patient.

We also provide drug discovery programs to identify novel therapies that may benefit certain patients.

Our technology will find the right drug for you.

  • Disease-Specific

    Focused

  • Patient-Specific

    Precise

  • High-throughput

    Scale

  • Minimally Invasive

    Easy

University of Toronto Hospital for Sick Children

OUR PUBLICATIONS

PubMed

Testimonials

PACKAGES

Choose from 3 Different Screening Options

OPTI-Rx™

Patient Pricing

USD$9,999

/SCREEN
  • Disease-Specific
  • Patient-Specific
  • Disease-Specific Drugs
  • Up to 80 Drugs Tested
  • Time to Completion: 1 Month

OPTI-FDA™

Patient Pricing

USD$TBD

/SCREEN
  • Disease-Specific
  • Patient-Specific
  • Disease-Specific Drugs
  • FDA-approved Drugs
  • Up to 1280 Drugs Tested
  • Time to Completion: 2 Months

DISCOVERY

Patient Pricing

USD$TBD

/SCREEN
  • Disease-Specific
  • Patient-Specific
  • Multi-Target
  • Disease-Specific & FDA-approved Drugs
  • Drug Discovery
  • Up to 100,000 Drugs Tested
  • Time to Completion: 6 Months

PURCHASE





Name, Email, Phone :


Our Team

Meet the Co-Founders
Saumel Ahmadi
Saumel Ahmadi
CEO
Saumel received his MD from Saurashtra University in India. He is currently completing his PhD (Physiology) at the University of Toronto while working at The Hospital for Sick Children.
Zoltán Bozóky
Zoltán Bozóky
CTO
Zoltan received his MSc (Chemistry) and PhD (Structural Biology) from the Eotvos Lorand University in Hungary. He also holds a Degree in Computer Science from the Graf Iskola kft. in Hungary. He recently completed his postdoctoral training at the Hospital for Sick Children.
Steven Molinski
Steven Molinski
CSO
Steven received his HonBSc (Toxicology) from the University of Toronto, MSc (Pharmacology) from Queen’s University, and PhD (Biochemistry) from the University of Toronto while working at The Hospital for Sick Children.

OUR OFFICES

40 Gerrard Street East
Toronto, ON, Canada
M5B 2M2
Borups Alle 126C, 2000
Copenhagen, Denmark

Contact Us

Request an Information Package

XVIVOS Biosciences - Enriching Therapeutic PotentialTM